IF YOU ARE A BRAND WHO FUNDED APPLICATION RP 427, THEN DEPENDING UPON YOUR PRODUCT TYPES AND THEIR STRENGTHS, THE OUTCOMES OF THE SAFETY ASSESSMENT MIGHT BE “SWEET”, “BITTERSWEET” OR JUST DOWNRIGHT “BITTER”

The UK FSA has recommended certain products from two CBD Brands for Authorisation under the Novel Foods approval process - but only at a level of 10 mg per day rather than the 50+ mg per day for which it is forcefully contended that there is evidence of safety.

THE PRACTICAL CONSEQUENCES OF THE CHANGE OF THE HOME OFFICE’S POLICY ON CONTROLLED CANNABINOIDS CONTENT IN CBD PRODUCTS

A SURPRISING ABOUT-TURN IN HOME OFFICE POLICY IN RESPECT OF “EXEMPT PRODUCTS” UNDER THE MISUSE OF DRUGS REGULATIONS

For the past 4 years, DevelRx and The Canna Consultants have worked in collaboration with the goal of achieving an objective and scientifically valid assessment the safety risks posed by the introduction of CBD as a novel food or food supplement.

THE FSA’s STANCE ON THE PUBLIC LIST FOLLOWING THEIR ADVICE TO LIMIT CBD INGESTION TO 10mg PER DAY – A CONTRADICTION IN TERMS

ADVICE REGARDING THE FSA’s REDUCTION IN THE RECOMMENDED DAILY INTAKE OF CBD FOLLOWING A MEETING WITH THEM HELD TODAY

THE WHOLE OF THE UK CBD INDUSTRY SUFFERS THE COLLATERAL DAMAGE CAUSED BY ONE CONSORTIUM’S POORLY DESIGNED STUDY

RESPONSE TO THE ATTACK ON OUR INTEGRITY BY THE ASSOCIATION FOR THE CANNABINOID INDUSTRY

The revocation of Jersey Hemp's cultivation, extraction and export licences by the Government of Jersey (at the behest of the UK Government) is unfortunate for all those involved in the business, but it is no surprise – it was inevitable.